Ekso Bionics Plans 510(k) For Robotic Exoskeleton Based On FDA Class II Designation
This article was originally published in The Gray Sheet
Executive Summary
The firm will submit a 510(k) later this month for its Ekso GT robotic skeleton, currently being marketed as a class I exempt device, based on feedback from FDA that robotic exoskeleton devices need to meet class II requirements.